NXTC

NextCure, Inc.

Healthcare · Biotechnology

$120.62 sample

-1.74 (-1.42%) 1D

Market cap

$317.7B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-29

Alerts

8

Price$120.62 +6.93% 3M daily closessample

122.36112.09

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29SECDEF 14A filed
Sep 18SEC8-K filed: material event
Sep 09SECDEF 14A filed
Sep 04INSInsider sell: 10% owner
Sep 01INSInsider sell: EVP, Operations
Aug 25INSInsider buy: Director
Aug 17INSInsider sell: EVP, Operations
Aug 06INSInsider sell: EVP, Operations

Sign up to see the real NXTC record →

Company facts

SEC EDGAR registration

Name: NextCure, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +43sample, -100 to +100
Reporting currency: USD

Who is positioning in NXTC

sample

Insiders: 24 insider transactions over 90 days, net selling, $654.8M
Congress: 5 members traded over 90 days
Institutions · 13F: 30 funds hold $2.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$17.7B +11.3% y/y

Q4 2024Q3 2026

Inventory$10.3B +9.6% y/y

Q4 2024Q3 2026

Accounts receivable$7.7B +11.0% y/y

Q4 2024Q3 2026

Total debt$21.3B +10.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $317.2B +11.3% 3M
Sample peer B: $68.9B -10.1% 3M
Sample peer C: $147.6B +13.5% 3M
Sample peer D: $201.7B -10.0% 3M
Sample peer E: $262.5B -2.6% 3M